Tenuta, M.; Pandozzi, C.; Sciarra, F.; Campolo, F.; Gelibter, A.J.; Sirgiovanni, G.; Cortesi, E.; Lenzi, A.; Isidori, A.M.; Sbardella, E.;
et al. Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia. Cancers 2023, 15, 3592.
https://doi.org/10.3390/cancers15143592
AMA Style
Tenuta M, Pandozzi C, Sciarra F, Campolo F, Gelibter AJ, Sirgiovanni G, Cortesi E, Lenzi A, Isidori AM, Sbardella E,
et al. Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia. Cancers. 2023; 15(14):3592.
https://doi.org/10.3390/cancers15143592
Chicago/Turabian Style
Tenuta, Marta, Carla Pandozzi, Francesca Sciarra, Federica Campolo, Alain J. Gelibter, Grazia Sirgiovanni, Enrico Cortesi, Andrea Lenzi, Andrea M. Isidori, Emilia Sbardella,
and et al. 2023. "Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia" Cancers 15, no. 14: 3592.
https://doi.org/10.3390/cancers15143592
APA Style
Tenuta, M., Pandozzi, C., Sciarra, F., Campolo, F., Gelibter, A. J., Sirgiovanni, G., Cortesi, E., Lenzi, A., Isidori, A. M., Sbardella, E., & Venneri, M. A.
(2023). Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia. Cancers, 15(14), 3592.
https://doi.org/10.3390/cancers15143592
